Geoff Meacham is a Managing Director in Americas Equity Research covering the Biotechnology and Major Pharmaceuticals sectors in the US. He has been with the firm since the fall of 2019. Meacham has been highly ranked in the Institutional Investor All-America Research Poll for over 10 years in the Large Cap Biotechnology Category and, more recently, the Major Pharma Category. Previously, he was a Managing Director at Barclays covering the US Biotech and Pharma sectors for 5 years and, prior to that, he was Managing Director at JPMorgan covering the US Biotech sector (large and SMid cap) for 10 years. Meacham began his career as an equity research analyst in 2000 at UBS, covering a number of sectors in Healthcare including SMid Biotech, Life Science Tools and SMid Med Tech. He has a Ph.D. in Molecular Cell Biology from the University of Alabama-Birmingham (UAB) and a BS in Biology / Microbiology from the University of Georgia. He is based in Atlanta, Georgia.
Geoff Meacham, PhD
Managing Director, Global Research, BofA Securities